16. Lubberts E, Schwarzenberger P, Huang W, Schurr J, Peschon J, et al. (2005) Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J Immunol 175: 3360–3368. 17. You Z, Shi X, Duraine G, Haudenschild D, Tepper C, et al. (2006) Interleukin- 17 receptor-like gene is a novel anti-apoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res 66: 175–183. 18. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, et al. (2003) Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48: 103–109. 19. Toh M, Yang Y, Leech M, Santos S, Morand EF (2004) Expression of MAP Kinase Phosphatase-1, a negative Regulator of MAP Kinases, in Rheumatoid Arthritis: Upregulation by IL-1 and Glucocorticoids. Arthritis Rheum 50: 3118–3128. 20. Borderie D, Hilliquin P, Hernvann A, Lemarechal H, Menkes C, et al. (1999) Apoptosis induced by nitric oxide is associated with nuclear p53 protein expression in cultured osteoarthritic synoviocytes. Osteoarthritis and Cartilage 7: 203–213. 21. Gotoh T, Oyadomari S, Mori K, Mori M (2002) Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem 277: 12343–12350. 22. Aupperle K, Boyle D, Hendrix M, Seftor E, Zvaifler N, et al. (1998) Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152: 1091–1098. 23. Zrioual S, Toh M, Tournadre A, Zhou Y, Cazalis M, et al. (2008) IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol 180: 655–663. 24. Zrioual S, Toh ML, Tournadre A, Zhou Y, Cazalis MA, et al. (2008) IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol 180: 655–663. 25. Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, et al. (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall- induced arthritis. Arthritis Rheum 52: 3239–3247. 26. Kaneko M, Ishiguro M, Niinuma Y, Uesugi M, Nomura Y (2002) Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Letters 532: 147–152. 27. Kikkert M, Doolman R, Dai M, Avner R, Hassink G, et al. (2004) Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem 279: 3525–3534. 28. Nadav E, Shmueli A, Barr H, Gonen H, Ciechanover A, et al. (2003) A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1. Biochem Biophys Res Commun 28: 91–97. 29. Yagishita N, Ohneda K, Amano T, Yamasaki S, Sugiura A, et al. (2005) Essential role of synoviolin in embryogenesis. J Biol Chem 280: 7909–7916. 30. Koenders M, Kolls J, Oppers-Walgreen B, van den Bersselaar L, Joosten L, et al. (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall–induced arthritis. Arthritis Rheum 52: 3239–3247. 31. Chen Q, Casali B, Pattacini L, Boiardi L, Salvarani C (2006) Tumour necrosis factor-a protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase akt signal transduction. J Rheumatol 33: 1061–1068. IL-17 and Synoviocyte Survival 32. Leech M, Lacey D, Xue J, Santos L, Hutchinson P, et al. (2003) Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 48: 1881–1889. 33. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, et al. (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177: 36–39. 34. Amano T, Yamasaki S, Yagishita N, Tsuchimochi K, Shin H, et al. (2003) Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev 17: 2436–2449. 35. Eizirik D, Flodstrom M, Karlsen A, Welsh N (1996) Diabetologia 39: 875–890. 36. Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, et al. (2001) Nitric oxide-induced apoptosis in pancreatic b cells is mediated by the endoplasmic reticulum stress pathway. PNAS 98: 10845–10850. 37. Borderie D, Hilliquin P, Hernvann A, Lemarechal H, Menkes C, et al. (1999) Apoptosis induced by nitric oxide is associated with nuclear p53 protein expression in cultured osteoarthritic synoviocytes. Osteoarthritis Cart 7: 203–213. 38. Hsu H, Yang P, Wang J, Wu Q, Myers R, et al. (2008) Interleukin-17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal centre development in autoimmune BXD2 mice. Nat Immunol 9: 166–175. 39. Cohen S, Emery P, Greenwald M, Dougados M, Furie R, et al. (2006) Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy results of a multicenter, randomized, double-blind, placebo-cntrolled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54: 2793–2806. 40. Anolik J, Ravikumar R, Barnard J, Owen T, Almudevar A, et al. (2008) Anti- tumour necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol 180: 688–692. 41. Arnett F, Edworthy S, Bloch D, McShane D, Fries J, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324. 42. Alessi D, Cuenda A, Cohen P, Dudley D, Saltiel A (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270: 27489–27494. 43. Lee J, Laydon J, McDonnell P, Gallagher T, Kumar S, et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739–746. 44. Bennett B, Sasaki D, Murray B, O’Leary E, Sakata S, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681–13686. 45. Toh M, Yang Y, Leech M, Santos S, Morand EF (in press, 1994) Expression of MAP Kinase Phosphatase-1, a Negative Regulator of MAP Kinases, in Rheumatoid Arthritis: Upregulation by IL-1 and Glucocorticoids. Arthritis Rheum. 46. Dufour J, Hemendinger R, Halberstadt C, Gores P, Emerich D, et al. (2004) Genetically engineered sertoli cells are able to survive allogeneic transplantation. Gene Therapy 11: 694–700. 47. Page G, Miossec P (2004) Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J Path 201: 28–38. 48. Toh M, Hong S, Franqueville L, Lindholm L, Boulanger P, et al. (2005) Enhancement of Adenovirus mediated Gene Delivery to Rheumatoid Arthritis Synoviocytes and Synovium by Fiber Modifications: Role of RGD- and non- RGD-binding Integrins. J Immunol 175: 7687–7698. PLoS ONE | www.plosone.org 13 October 2010 | Volume 5 | Issue 10 | e13416